DBPR108: Clinical Trials

2 trials of DBPR108, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow DBPR108: new trials by email Literature Review of DBPR108 trials Research Report on DBPR108

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
DBPR108, metformin hydrochloride, placepo - Type 2 Diabetes Mellitus
Phase 3CompletedCSPC ZhongQi Pharmaceutical Technology Co., Ltd.2142020-01-142021-06-28
A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients
DBPR108; Placebo matching sitagliptin, Placebo matching DBPR108; Sitagliptin; DBPR108, Placebo matching DBPR108; Placebo matching sitagliptin; DBPR108 - Type 2 Diabetes Mellitus
Phase 3CompletedCSPC ZhongQi Pharmaceutical Technology Co., Ltd.7662020-01-022022-08-17

Conditions studied

Diabetes Mellitus, Type 2 (2)

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (2)

Countries

China (2)

Top investigators

Kun Lou (2)